HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.

Abstract
Shrews, insectivorous small mammals, pertain to an ancient mammalian order. We screened 693 European and African shrews for hepatitis B virus (HBV) homologs to elucidate the enigmatic genealogy of HBV. Shrews host HBVs at low prevalence (2.5%) across a broad geographic and host range. The phylogenetically divergent shrew HBVs comprise separate species termed crowned shrew HBV (CSHBV) and musk shrew HBV (MSHBV), each containing distinct genotypes. Recombination events across host orders, evolutionary reconstructions, and antigenic divergence of shrew HBVs corroborated ancient origins of mammalian HBVs dating back about 80 million years. Resurrected CSHBV replicated in human hepatoma cells, but human- and tupaia-derived primary hepatocytes were resistant to hepatitis D viruses pseudotyped with CSHBV surface proteins. Functional characterization of the shrew sodium taurocholate cotransporting polypeptide (Ntcp), CSHBV/MSHBV surface peptide binding patterns, and infection experiments revealed lack of Ntcp-mediated entry of shrew HBV. Contrastingly, HBV entry was enabled by the shrew Ntcp. Shrew HBVs universally showed mutations in their genomic preCore domains impeding hepatitis B e antigen (HBeAg) production and resembling those observed in HBeAg-negative human HBV. Deep sequencing and in situ hybridization suggest that HBeAg-negative shrew HBVs cause intense hepatotropic monoinfections and low within-host genomic heterogeneity. Geographical clustering and low MSHBV/CSHBV-specific seroprevalence suggest focal transmission and high virulence of shrew HBVs. HBeAg negativity is thus an ancient HBV infection pattern, whereas Ntcp usage for entry is not evolutionarily conserved. Shrew infection models relying on CSHBV/MSHBV revertants and human HBV will allow comparative assessments of HBeAg-mediated HBV pathogenesis, entry, and species barriers.
AuthorsAndrea Rasche, Felix Lehmann, Alexander König, Nora Goldmann, Victor M Corman, Andres Moreira-Soto, Andreas Geipel, Debby van Riel, Yulia A Vakulenko, Anna-Lena Sander, Hauke Niekamp, Ramona Kepper, Mathias Schlegel, Chantal Akoua-Koffi, Breno F C D Souza, Foday Sahr, Ayodeji Olayemi, Vanessa Schulze, Rasa Petraityte-Burneikiene, Andris Kazaks, Kira A A T Lowjaga, Joachim Geyer, Thijs Kuiken, Christian Drosten, Alexander N Lukashev, Elisabeth Fichet-Calvet, Rainer G Ulrich, Dieter Glebe, Jan Felix Drexler
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 116 Issue 34 Pg. 17007-17012 (08 20 2019) ISSN: 1091-6490 [Electronic] United States
PMID31371507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Viral Envelope Proteins
  • Virulence Factors
Topics
  • Animals
  • Cell Line, Tumor
  • Evolution, Molecular
  • Hepatitis B (genetics, metabolism, veterinary)
  • Hepatitis B virus (genetics, metabolism, pathogenicity)
  • Humans
  • Models, Genetic
  • Phylogeny
  • Shrews (virology)
  • Viral Envelope Proteins (genetics)
  • Virulence Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: